Balyasny Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Balyasny Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$894K	Buy	+27,039	New	+$1.14M	﹤0.01%	2128
2025 Q2	–	Sell	-46,993	Closed	-$1.4M	–	2895
2025 Q1	$1.4M	Buy	+46,993	New	+$1.44M	﹤0.01%	1857
2024 Q1	–	Sell	-14,818	Closed	-$456K	–	2687
2023 Q4	$456K	Buy	+14,818	New	+$371K	﹤0.01%	1991
2023 Q1	–	Sell	-167,816	Closed	-$3.89M	–	2721
2022 Q4	$3.89M	Buy	+167,816	New	+$3.38M	0.01%	1132
2020 Q1	–	Sell	-10,618	Closed	-$219K	–	1205
2019 Q4	$219K	Buy	+10,618	New	+$177K	﹤0.01%	1095
2018 Q4	–	Sell	-33,712	Closed	-$497K	–	1451
2018 Q3	$497K	Buy	+33,712	New	+$598K	﹤0.01%	1384
2018 Q2	–	Sell	-17,520	Closed	-$448K	–	1823
2018 Q1	$448K	Buy	+17,520	New	+$417K	﹤0.01%	1476

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Balyasny Asset Management's COLL Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q1 2026: 27,039 shares worth $894K. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in COLL as recently as Q1 2025.

Balyasny Asset Management first reported a position in COLL in Q1 2018 and has held it in 7 quarters since. The position peaked at $3.89M in Q4 2022. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Balyasny Asset Management held 27,039 shares of Collegium Pharmaceutical worth $894K as of Q1 2026.
Collegium Pharmaceutical was a new Balyasny Asset Management position in Q1 2026.
Collegium Pharmaceutical made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2128 holding.
Balyasny Asset Management first reported a position in Collegium Pharmaceutical in Q1 2018 and has held it in 7 quarters since.
Balyasny Asset Management's Collegium Pharmaceutical position peaked at $3.89M in Q4 2022.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.